Immix Biopharma, Inc. - Common Stock (IMMX)

$2.30 0.17 (7.75%)

13:25 EDT IMMX Stock Quote Delayed 30 Minutes

IMMX Stock Earnings: Immix Biopharma Misses EPS for Q4 2023

By InvestorPlace Earnings Apr 2, 2024

IMMX stock results show that Immix Biopharma missed analyst estimates for earnings per share the fourth quarter of 2023.

The 3 Best Speculative Stocks to Buy Now: September 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 53,071

Day's Range $2.08 - $2.35

52-Week Range $1.40 - $7.75

Dividend & Yield N/A (N/A)

IMMX Stock Predictions, Articles, and Immix Biopharma, Inc. - Common Stock News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 16, 2022

Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday!

5 Short-Squeeze Candidates to Watch Today: IMMX, ALTM, GLTB, CRTX and TSRI

By William White, InvestorPlace Writer Feb 1, 2022

Short-squeeze stocks continue to be hot with traders and we're going over five candidates that investors will want to watch today.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jan 7, 2022

It's the final day of trading this week and we're starting it off with an overview of the biggest pre-market stock movers for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jan 4, 2022

Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday!

IMMX Stock Alert: The Massive FDA Win That Has Immix Biopharma Blasting Higher Today

By William White, InvestorPlace Writer Jan 3, 2022

Immix Biopharma (IMMX) stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Dec 20, 2021

The weekend break is over and that means it's time to get back to work with the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Dec 17, 2021

Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday!

Immix Biopharma looks to raise capital to equity offering (NASDAQ:IMMX)

From Seeking Alpha Feb 5, 2024

Read about Immix Biopharma's plans to offer shares in an underwritten public offering to fund clinical trials and support corporate operations.

FDA okays US clinical testing for Immix drug NXC-201 (NASDAQ:IMMX)

From Seeking Alpha Nov 21, 2023

Immix (IMMX) has receives FDA clearance to begin US clinical testing for its drug NXC-201 in the treatment of AL amyloidosis. Read more here.

Immix Biopharma files to sell 5.15M shares of common stock for holders (NASDAQ:IMMX)

From Seeking Alpha Sep 25, 2023

Immix Biopharma (IMMX) plans to sell 5.15M shares of common stock for holders, as per the SEC filing. Read more on Seeking Alpha.

Immix stock gains on FDA orphan drug status (NASDAQ:IMMX)

From Seeking Alpha Sep 21, 2023

Immix Biopharma (IMMX) said Thursday the FDA issued the Orphan Drug Designation for its CAR-T cell therapy NXC-201 as a treatment for AL amyloidosis. Read more here.

Immix Biopharma director acquires $2M worth of shares (NASDAQ:IMMX)

From Seeking Alpha Sep 19, 2023

Immix Biopharma (IMMX) Director Hsu Jason acquired $2M worth of shares in the biotechnology company.

ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug

From Benzinga May 20, 2022

ADVERTISEMENT